Wendy Chung is a clinical and molecular geneticist and leads the Precision Medicine Resource in the Irving Institute at Columbia University. She directs 8 NIH funded research programs across many different diseases. She is a national leader in the ethical, legal, and social implications of genomics. She has authored over 400 peer-reviewed papers and 50 reviews and chapters in medical texts. She received the Rare Impact Award from NORD and the Columbia Presidential Award for Outstanding Teaching. She was the original plaintiff in the Supreme Court case that overturned the ability to patent genes.